In an era where scientific breakthroughs demand speed, precision, and scalability, Ginkgo Bioworks stands at the forefront of a transformative movement in the biotech industry by harnessing artificial intelligence (AI) to redefine lab automation. With the global lab automation market currently
What if the erratic rhythm of millions of hearts could be decoded not by a stethoscope, but by the raw power of supercomputers? Atrial fibrillation (AF), the most common type of irregular heartbeat, silently threatens lives worldwide, often leading to devastating strokes. This condition,
Imagine a world where millions of people struggle with high cholesterol, a silent threat that fuels heart disease, yet many cannot tolerate standard treatments like statins due to side effects or poor response, leaving them at risk. This pressing challenge affects countless lives, with
Imagine a world where complex cardiac arrhythmias, conditions that disrupt the heart's rhythm and pose significant health risks, can be diagnosed and treated with unprecedented precision and safety. This vision is becoming a reality with the recent U.S. Food and Drug Administration (FDA) clearance
Imagine a world where a cancer diagnosis no longer carries the weight of uncertainty, where treatments are tailored to the unique makeup of each patient, and where technology detects the disease before symptoms even appear. This vision is rapidly becoming reality as oncology undergoes a profound
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the industry. With a strong background in research and development, Ivan brings a unique perspective on the evolving landscape of telehealth. Today, we’re diving into the
